GSK launches shingles vaccine, Shingrix in India EP News Bureau Apr 25, 2023 Shingrix is a non-live, recombinant subunit vaccine to be given intramuscularly in two doses for the prevention of shingles…
EC approves expanded indication for Merck’s Pneumococcal 15-valent Conjugate Vaccine EP News Bureau Oct 27, 2022 The approval facilitates availability of Vaxneuvance for this population in all 27 European Union (EU) member states plus Iceland,…
SIGA gets international procurement orders worth $16 million for Oral TPOXX (Tecovirimat) EP News Bureau Sep 27, 2022 Order for approximately $10 million funded by the European Commission and orders for approximately $6 million received from two…
European Commission approves Roche’s Vabysmo to treat vision loss EP News Bureau Sep 19, 2022 Vabysmo is the only injectable eye medicine approved in Europe with phase-III studies supporting treatment at intervals of up to…
EU signs joint procurement deal with Spain’s HIPRA for COVID vaccines Reuters Aug 4, 2022 The European Union's executive said in a statement that 14 countries are participating in the agreement, under which they can…
European Commission approves Pfizer’s Cibinqo to treat adults with moderate-to-severe atopic… EP News Bureau Dec 13, 2021 Cibinqo is a once-daily oral treatment with proven efficacy demonstrated in a large-scale clinical trial programme
European Commission approves Roche’s Gavreto to treat adults with RET fusion-positive advanced… EP News Bureau Nov 22, 2021 Gavreto is the first and only precision medicine approved in the EU for the first-line treatment of people with RET…
European Commission approves Ronapreve to treat non-hospitalised COVID-19 patients EP News Bureau Nov 16, 2021 The decision follows one day after the positive opinion by the EMA Committee for CHMP, reflecting the EMA and the European…
AstraZeneca and European Commission reach settlement agreement over vaccine supply, ending… EP News Bureau Sep 6, 2021 Under the agreement, AstraZeneca commits to deliver 60 million doses of the vaccine by the end of the third quarter 2021, 75…
Xeljanz receives marketing authorisation in EU to treat active polyarticular juvenile idiopathic… EP News Bureau Aug 23, 2021 This once-daily treatment is an alternative to the currently-approved Xeljanz 5 mg twice-daily treatment of PsA